| Position: Home>Women Health> |
| Position: Home>Women Health> |
NEW YORK - In the year since it was approved for over-the-counter sales, the morning-after pill has become a huge commercial success for its manufacturer, but its popularity and solid safety record haven’t deterred critics from seeking to overturn the milestone ruling.
The pill, marketed by Barr Pharmaceuticals Inc. as Plan B, was the focus of bitter debate for three years. After repeated delays, the Food and Drug Administration declared on Aug. 24, 2006 that customers 18 and older should be able to buy it in pharmacies without a prescription.
Barr began distributing the over-the-counter version last November, and all national pharmacy chains now stock it. The company projects that sales of Plan B will total about $80 million for 2007, almost double the total for 2006 and up eightfold from 2004, when Barr acquired the product as a prescription-only drug.
“Overall, we’ve been very pleased with the acceptance,” said Barr spokeswoman Carol Cox. “The product may not be for everyone — but if you find yourself in a position to need it, absolutely it should be available.”
Despite the booming sales, and evidence that the pill is safe if properly used, critics remain active.
Applying political pressure
A coalition of conservative groups, including the Family Research Council and Concerned Women for America, has filed a lawsuit in federal court in Washington seeking to reverse the FDA ruling. The groups contend that the FDA acted unwisely under political pressure and lacked authority to approve the same drug for both over-the-counter and prescription-only distribution based on the user’s age.
![]() |
Barr says Plan B, a high dose of a drug found in many regular birth-control pills, can lower the risk of pregnancy by up to 89 percent if taken within 72 hours of unprotected sex.
Since the FDA ruling, there have been extensive efforts by advocacy groups and some politicians to ensure widespread availability of Plan B.
|
Top Stories
FRIDAY, Feb. 2 (HealthDay News) -- People who spend a lot of time behind the wheel may b
WEDNESDAY, Feb. 7 (HealthDay News) -- A new monoclonal antibody drug produced dramatic i
TUESDAY, Feb. 13 (HealthDay News) -- Many patients with moderate to severe chronic psori
FRIDAY, Feb. 9 (HealthDay News) -- A neuropeptide called melanin concentrating hormone (
MONDAY, Feb. 12 (HealthDay News) -- Extensive genetic analysis has uncovered a gene vari
MONDAY, Feb. 12 (HealthDay News) -- Postmenopausal breast cancer patients who switch fro
|
|
Related
NEW YORK - Women who have their ovaries removed before menopause run a heightened risk o Dreading your next visit? We can read your mindand help you fight your fears. I hate tho Melissa Dahl Health writer E-mail During her sophomore year of high school, Jennifer Rob TUESDAY, Jan. 16 (HealthDay News) -- More American families -- both with health insuranc
Triplets born to woman with 2 wombs First case of its kind, British hospital official sa
Herbal treatment little help for menopause Black cohosh not effective in relieving hot f
Despite cancer risk, some need hormones Docs worry severely menopausal women with won't
Morning-after pill on shelves, but debate rages Plan B now available at pharmacies natio
|

LOOKING
FOR
ADVERTISEMENT
